Results 11 to 20 of about 25,138 (263)

Loop diuretics association with Alzheimer’s disease risk [PDF]

Frontiers in Aging, 2023
Objectives: To investigate whether exposure history to two common loop diuretics, bumetanide and furosemide, affects the risk of developing Alzheimer’s disease (AD) after accounting for socioeconomic status and congestive heart failure.Methods ...
Anna Graber-Naidich, Justin Lee, Kyan Younes, Michael D. Greicius, Yann Le Guen, Yann Le Guen, Zihuai He, Zihuai He   +7 more
doaj   +2 more sources

Continuous Versus Intermittent Loop Diuretics Step‐by‐Step Protocol in Acute Heart Failure (DIUR‐AHF): A Propensity‐Matched Analysis [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Loop diuretics are used to solve congestion in acute heart failure. However, a clear indication about the best infusion modality, dose, and duration of the treatment has not yet been established.
Gaetano Ruocco, Andrea Salzano, Sara Franceschi, Roberto Lorusso, Filippo Pirrotta, Andrea Stefanini, Antonio Pagliaro, Paolo Severino, Andrea D’Amato, Carmine D. Vizza, Giulia Crisci, Marco Guazzi, Simone Frea, Guido Pastorini, Mauro Feola, Francesco Fedele, Alberto Palazzuoli   +16 more
doaj   +2 more sources

Drug–drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports [PDF]

Scientific Reports, 2023
Teicoplanin can cause acute kidney injury, but little is known about the risk of acute kidney injury when teicoplanin is co-administered with loop diuretics (a powerful diuresis), which can alter renal hemodynamics and glomerular filtration rate.
Toshinori Hirai, Yuki Kondo, Yuka Sakazaki, Ayaka Seki, Yoichi Ishitsuka, Takuya Iwamoto   +5 more
doaj   +2 more sources

Loop diuretics have anxiolytic effects in rat models of conditioned anxiety. [PDF]

PLoS ONE, 2012
A number of antiepileptic medications that modulate GABA(A) mediated synaptic transmission are anxiolytic. The loop diuretics furosemide (Lasix) and bumetanide (Bumex) are thought to have antiepileptic properties.
Andrew D Krystal, Janice Sutherland, Daryl W Hochman   +2 more
doaj   +3 more sources

Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis [PDF]

Journal of Pharmaceutical Health Care and Sciences
Background We examined whether denosumab-induced hypocalcaemia is evident in osteoporosis when given loop diuretics that promote urinary calcium excretion.
Toshinori Hirai, Yukari Mori, Toru Ogura, Yuki Kondo, Yuka Sakazaki, Yoichi Ishitsuka, Akihiro Sudo, Takuya Iwamoto   +7 more
doaj   +2 more sources

Ototoxic effects and mechanisms of loop diuretics

Journal of Otology, 2016
Over the past two decades considerable progress has been made in understanding the ototoxic effects and mechanisms underlying loop diuretics. As typical representative of loop diuretics ethacrynic acid or furosemide only induces temporary hearing loss ...
Dalian Ding, Hong Liu, Weidong Qi, Haiyan Jiang, Yongqi Li, Xuewen Wu, Hong Sun, Kenneth Gross, Richard Salvi   +8 more
doaj   +2 more sources

Combination of SGLT2 Inhibitors and Loop Diuretics in the Treatment of Heart Failure. [PDF]

J Pers Med
Background: Administration of SGLT2 inhibitors leads to a reduction in the dosage of loop diuretics in heart failure (HF) patients; however, it is unclear in what patients the dosage can be reduced. We investigated the factors related to the reduction in
Murakami Y, Kiuchi S, Hisatake S, Ikeda T.   +3 more
europepmc   +2 more sources

Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure

Journal of the American College of Cardiology, 2010
Volume overload is an important clinical target in heart failure management, typically addressed using loop diuretics. An important and challenging subset of heart failure patients exhibit fluid overload despite significant doses of loop diuretics.
Jacob C Jentzer, Tracy A Dewald
exaly   +2 more sources

Impact of Loop Diuretics on Long-Term Kidney Outcome: A Post Hoc Analysis of the STOP-Angiotensin-Converting Enzyme Inhibitor Trial. [PDF]

Kidney360
Background: In the STOP-ACEi trial, patients with advanced CKD were randomised to continue or stop renin–angiotensin system inhibitors (RASi) and showed no difference in kidney outcomes. This post-hoc analysis investigates interactions with loop diuretic
Bhandari S, Mehta S, Ives N, Cleland JGF, Cockwell P.   +4 more
europepmc   +4 more sources

Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis [PDF]

Renal Failure, 2023
Background Concern exists regarding the renal safety of blocking the renin-angiotensin system (RAS) during acute illness, especially in the presence of volume depletion and hemodynamic instability.Methods We explored the impact of loop diuretics and RAS ...
May Assaly, Yuri Gorelik, Samuel N. Heyman, Zaid Abassi, Mogher Khamaisi   +4 more
doaj   +2 more sources